Market Dynamics and Growth Prospects The dramatic weight loss results achieved with GLP-1 agonistsoften between 15-25%have spurred market growth, far surpassing the performance of earlier medications
There is no one way to switch that is recommended for everyone
Makes skin feel soft and smooth
For early to moderate type 2 diabetes, GLP-1 medications are increasingly preferred due to weight loss benefits, lower hypoglycemia risk, and cardiovascular protection
Clinicians managing patients on testosterone who wish to explore retatrutide should: Consult the relevant clinical trial protocols if the patient is enrolled in a study Seek specialist endocrinology input before initiating any off-label or investigational combination Document clinical rationale clearly , obtain informed consent, and follow GMC Good Practice in Prescribing and Managing Medicines and Devices guidance when considering unlicensed or investigational treatments Until formal guidance is available, clinical decision-making should be guided by individual patient riskbenefit assessment, informed consent, and regular monitoring